ArticleAsian Pacific journal of cancer prevention : APJCP2025
Evaluation of Therapeutic Activity of Tualang Honey on Oral Cancer: Histopathological Study.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe use of natural products has been gaining interest, notably, in the area of cancer therapy. In this study, we determined the chemotherapeutic activity of Tualang Honey (TH) Malaysian wild local honey, on an animal model induced for oral cancer using 4NQO.
methodsA total of 28 male Sprague-Dawley (SD) rats were randomized into four groups (n=7 per group) as non-treated, treated (1000 mg/kg) 1000, treated 2000 mg/kg and control group. All groups' rats received 4NQO, followed by 10 weeks administration of TH at 1000 and 2000 mg/kg, respectively, for the treated groups. All rats from all experiments were sacrificed to evaluate the incidence of oral neoplasms with histopathological changes and histological evaluation of oral cancer metastasis.
resultsTH significantly reduced the incidence of SCC from 100% to 28.6 % in the TH high dose group of 2000 mg/kg. furthermore, TH has the ability to inhibit the metastasis of oral cancer to adjacent organs.
conclusionTH inhibited the proliferation of the cancer cells in an animal model of oral squamous cell carcinoma and therefore, has the potential to be developed as a chemotherapeutic agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.